The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Global Hyposensitization market is projected to reach US$ 2546.7 million in 2029, increasing from US$ 1586 million in 2022, with the CAGR of 7.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyposensitization market research.
The market driver for Desensitization Treatment is the increasing prevalence of allergies and the growing need for effective allergy management. Desensitization treatment, also known as immunotherapy, offers a potential cure for allergies by reducing sensitivity to allergens. Rising awareness of the treatment's benefits and advancements in allergy research contribute to market growth. However, challenges include the lengthy treatment duration, potential side effects, and the need for personalized treatment plans. Additionally, reimbursement issues and the availability of alternative allergy management options may pose challenges for market adoption. Despite challenges, the Desensitization Treatment market presents opportunities for improved patient outcomes and better quality of life for individuals with allergies, driving further research and innovation in allergy care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hyposensitization market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- WOLW Pharma
- HAL
- Holister Stier
- Leti
Segment by Type
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Segment by Application
- Allergic Rhinitis
- Allergic Asthma
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Hyposensitization report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyposensitization Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Hyposensitization Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyposensitization Market Perspective (2018-2029)
2.2 Hyposensitization Growth Trends by Region
2.2.1 Global Hyposensitization Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hyposensitization Historic Market Size by Region (2018-2023)
2.2.3 Hyposensitization Forecasted Market Size by Region (2024-2029)
2.3 Hyposensitization Market Dynamics
2.3.1 Hyposensitization Industry Trends
2.3.2 Hyposensitization Market Drivers
2.3.3 Hyposensitization Market Challenges
2.3.4 Hyposensitization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyposensitization Players by Revenue
3.1.1 Global Top Hyposensitization Players by Revenue (2018-2023)
3.1.2 Global Hyposensitization Revenue Market Share by Players (2018-2023)
3.2 Global Hyposensitization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hyposensitization Revenue
3.4 Global Hyposensitization Market Concentration Ratio
3.4.1 Global Hyposensitization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyposensitization Revenue in 2022
3.5 Hyposensitization Key Players Head office and Area Served
3.6 Key Players Hyposensitization Product Solution and Service
3.7 Date of Enter into Hyposensitization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyposensitization Breakdown Data by Type
4.1 Global Hyposensitization Historic Market Size by Type (2018-2023)
4.2 Global Hyposensitization Forecasted Market Size by Type (2024-2029)
5 Hyposensitization Breakdown Data by Application
5.1 Global Hyposensitization Historic Market Size by Application (2018-2023)
5.2 Global Hyposensitization Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hyposensitization Market Size (2018-2029)
6.2 North America Hyposensitization Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hyposensitization Market Size by Country (2018-2023)
6.4 North America Hyposensitization Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hyposensitization Market Size (2018-2029)
7.2 Europe Hyposensitization Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hyposensitization Market Size by Country (2018-2023)
7.4 Europe Hyposensitization Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hyposensitization Market Size (2018-2029)
8.2 Asia-Pacific Hyposensitization Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hyposensitization Market Size by Region (2018-2023)
8.4 Asia-Pacific Hyposensitization Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hyposensitization Market Size (2018-2029)
9.2 Latin America Hyposensitization Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hyposensitization Market Size by Country (2018-2023)
9.4 Latin America Hyposensitization Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyposensitization Market Size (2018-2029)
10.2 Middle East & Africa Hyposensitization Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hyposensitization Market Size by Country (2018-2023)
10.4 Middle East & Africa Hyposensitization Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ALK-Abello
11.1.1 ALK-Abello Company Detail
11.1.2 ALK-Abello Business Overview
11.1.3 ALK-Abello Hyposensitization Introduction
11.1.4 ALK-Abello Revenue in Hyposensitization Business (2018-2023)
11.1.5 ALK-Abello Recent Development
11.2 Stallergenes Greer
11.2.1 Stallergenes Greer Company Detail
11.2.2 Stallergenes Greer Business Overview
11.2.3 Stallergenes Greer Hyposensitization Introduction
11.2.4 Stallergenes Greer Revenue in Hyposensitization Business (2018-2023)
11.2.5 Stallergenes Greer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Hyposensitization Introduction
11.3.4 Merck Revenue in Hyposensitization Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Company Detail
11.4.2 Allergy Therapeutics Business Overview
11.4.3 Allergy Therapeutics Hyposensitization Introduction
11.4.4 Allergy Therapeutics Revenue in Hyposensitization Business (2018-2023)
11.4.5 Allergy Therapeutics Recent Development
11.5 WOLW Pharma
11.5.1 WOLW Pharma Company Detail
11.5.2 WOLW Pharma Business Overview
11.5.3 WOLW Pharma Hyposensitization Introduction
11.5.4 WOLW Pharma Revenue in Hyposensitization Business (2018-2023)
11.5.5 WOLW Pharma Recent Development
11.6 HAL
11.6.1 HAL Company Detail
11.6.2 HAL Business Overview
11.6.3 HAL Hyposensitization Introduction
11.6.4 HAL Revenue in Hyposensitization Business (2018-2023)
11.6.5 HAL Recent Development
11.7 Holister Stier
11.7.1 Holister Stier Company Detail
11.7.2 Holister Stier Business Overview
11.7.3 Holister Stier Hyposensitization Introduction
11.7.4 Holister Stier Revenue in Hyposensitization Business (2018-2023)
11.7.5 Holister Stier Recent Development
11.8 Leti
11.8.1 Leti Company Detail
11.8.2 Leti Business Overview
11.8.3 Leti Hyposensitization Introduction
11.8.4 Leti Revenue in Hyposensitization Business (2018-2023)
11.8.5 Leti Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
